Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A 24 week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the
efficacy and safety of 18mcg of tiotropium inhalation capsules administered by Handihaler
once daily plus Pro Re Nata (PRN) albuterol (salbutamol) vs. placebo plus PRN albuterol
(salbutamol) in chronic obstructive pulmonary disease subjects naive to maintenance therapy.